Study of ENMD-2076 in Patients With Multiple Myeloma
| Status: | Archived |
|---|---|
| Conditions: | Blood Cancer, Hematology |
| Therapuetic Areas: | Hematology, Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | December 2008 |
| End Date: | May 2010 |
A Phase 1 Study of ENMD-2076 in Patients With Relapsed or Refractory Multiple Myeloma
The study is designed to assess the safety, tolerability, maximum tolerated dose, and
clinical benefit of treatment with ENMD-2076 administered orally once daily over a range of
doses in patients with relapsed or refractory multiple myeloma.
We found this trial at
1
site
Click here to add this to my saved trials
